These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Time course of the acetazolamide effect in patients with extracranial carotid artery disease. Stoll M, Hamann GF, Jost V, Bompotti UA, Fitridge R, Schimrigk K. J Neuroimaging; 1996 Jul; 6(3):144-9. PubMed ID: 8704288 [Abstract] [Full Text] [Related]
7. Assessment of cerebral vasomotor reactivity by transcranial Doppler ultrasound and breath-holding. A comparison with acetazolamide as vasodilatory stimulus. Müller M, Voges M, Piepgras U, Schimrigk K. Stroke; 1995 Jan; 26(1):96-100. PubMed ID: 7839406 [Abstract] [Full Text] [Related]
12. Influence of acetazolamide and CO2 on extracranial flow volume and intracranial blood flow velocity. Eicke BM, Buss E, Bähr RR, Hajak G, Paulus W. Stroke; 1999 Jan; 30(1):76-80. PubMed ID: 9880392 [Abstract] [Full Text] [Related]
13. SPECT measurements of cerebral blood volume before and after acetazolamide in occlusive cerebrovascular diseases. Inoue Y, Momose T, Machida K, Honda N, Nishikawa J, Sasaki Y. Radiat Med; 1994 Jan; 12(5):225-9. PubMed ID: 7863027 [Abstract] [Full Text] [Related]